Misu Lee

1.7k total citations
59 papers, 961 citations indexed

About

Misu Lee is a scholar working on Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Misu Lee has authored 59 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 19 papers in Cancer Research and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Misu Lee's work include Cancer, Hypoxia, and Metabolism (17 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Neuroendocrine Tumor Research Advances (9 papers). Misu Lee is often cited by papers focused on Cancer, Hypoxia, and Metabolism (17 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Neuroendocrine Tumor Research Advances (9 papers). Misu Lee collaborates with scholars based in South Korea, Germany and Italy. Misu Lee's co-authors include Natalia S. Pellegata, Mijin Yun, Jae‐Chul Pyun, Federico Roncaroli, Jong‐Ho Kim, In-San Kim, Ick Chan Kwon, Hyungkyu Park, Hesson Chung and Kuiwon Choi and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Scientific Reports.

In The Last Decade

Misu Lee

54 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Misu Lee South Korea 18 417 194 187 177 164 59 961
Sanjay Thamake United States 15 334 0.8× 154 0.8× 107 0.6× 235 1.3× 39 0.2× 28 791
Ronald J. Bernardi United States 13 673 1.6× 168 0.9× 94 0.5× 291 1.6× 64 0.4× 14 1.3k
Letícia Labriola Brazil 20 538 1.3× 168 0.9× 88 0.5× 316 1.8× 197 1.2× 43 1.6k
Heming Li China 19 506 1.2× 325 1.7× 61 0.3× 475 2.7× 59 0.4× 60 1.1k
Patrick Delavault France 9 315 0.8× 150 0.8× 198 1.1× 206 1.2× 29 0.2× 15 1.3k
Mozhdeh Sojoodi United States 20 482 1.2× 153 0.8× 197 1.1× 447 2.5× 93 0.6× 38 1.4k
Pietro Di Fazio Germany 26 980 2.4× 336 1.7× 374 2.0× 505 2.9× 91 0.6× 78 1.7k
Mikhail M. Dikov United States 20 868 2.1× 240 1.2× 82 0.4× 604 3.4× 111 0.7× 31 1.9k
Hisanori Kosuge Japan 25 460 1.1× 155 0.8× 116 0.6× 166 0.9× 39 0.2× 68 1.6k
Weiye Deng United States 19 419 1.0× 186 1.0× 93 0.5× 623 3.5× 26 0.2× 43 1.5k

Countries citing papers authored by Misu Lee

Since Specialization
Citations

This map shows the geographic impact of Misu Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misu Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misu Lee more than expected).

Fields of papers citing papers by Misu Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misu Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misu Lee. The network helps show where Misu Lee may publish in the future.

Co-authorship network of co-authors of Misu Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Misu Lee. A scholar is included among the top collaborators of Misu Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misu Lee. Misu Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Josephine, Kyumin Kim, Shaoqing Ju, et al.. (2025). T-cell engaging bispecific outer membrane vesicles (BiTE-OMV) for targeted prostate cancer immunotherapy. Journal of Drug Delivery Science and Technology. 107. 106762–106762. 1 indexed citations
2.
Piccinini, Filippo, Jae‐Chul Pyun, Misu Lee, et al.. (2025). ColorI-DT: An open-source tool for the quantitative evaluation of differences in microscopy color images. Computational and Structural Biotechnology Journal. 27. 2526–2536.
3.
Jung, Jaeyong, Jeong Soo Sung, Soonil Kwon, et al.. (2025). Transmembrane protease serine 2 (TMPRSS2) inhibitors screened from an Fv-antibody library for preventing SARS-CoV-2 infection. RSC Medicinal Chemistry. 16(4). 1758–1765.
4.
Lee, Soo Jeong, Jaeyong Jung, Jeong Soo Sung, et al.. (2024). Surface Plasmon Resonance (SPR) Biosensor for the Detection of SARS-CoV-2 Using Autodisplyaed FV-antibodies on Outer Membrane of E. coli. BioChip Journal. 18(1). 146–159. 14 indexed citations
5.
Jung, Kyung Hee, Su-Jin Lee, Han Sun Kim, et al.. (2024). Acetyl-CoA synthetase 2 contributes to a better prognosis for liver cancer by switching acetate-glucose metabolism. Experimental & Molecular Medicine. 56(3). 721–733. 4 indexed citations
6.
Jung, Jaeyong, Jeong Soo Sung, Soonil Kwon, et al.. (2024). Preventing SARS-CoV-2 infection using Fv-antibodies targeting the proprotein convertase (PPC) cleavage site. RSC Medicinal Chemistry. 15(11). 3704–3710. 1 indexed citations
7.
Sung, Jeong Soo, Jaeyong Jung, Taehun Kim, et al.. (2024). Monocarboxylate transporter-1 (MCT-1) inhibitors screened from autodisplayed FV-antibody library. International Journal of Biological Macromolecules. 265(Pt 1). 130854–130854. 8 indexed citations
8.
Kim, Jimin, Sanghee Park, Seunghwan Kim, et al.. (2024). Enhancing the anticancer effect of androgen deprivation therapy by monocarboxylate transporter 1 inhibitor in prostate cancer cells. The Prostate. 84(9). 814–822. 2 indexed citations
9.
Kim, Ji Su, Seung Hwan Lee, Dongwoo Kim, et al.. (2024). Combination of [18F]FDG and [18F]PSMA-1007 PET/CT predicts tumour aggressiveness at staging and biochemical failure postoperatively in patients with prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 51(6). 1763–1772. 10 indexed citations
10.
Lee, Misu, et al.. (2024). Covalent coupling of functionalized outer membrane vesicles (OMVs) to gold nanoparticles. Journal of Colloid and Interface Science. 663. 227–237. 6 indexed citations
11.
Jung, Jaeyong, Jeong Soo Sung, Soon Kil Kwon, et al.. (2023). One-step immunoassay of SARS-CoV-2 using screened Fv-antibodies and switching peptides. Biosensors and Bioelectronics. 245. 115834–115834. 10 indexed citations
12.
Kim, Dongwoo, Ji Su Kim, Hae Young Ko, et al.. (2022). Extracellular Citrate Treatment Induces HIF1α Degradation and Inhibits the Growth of Low-Glycolytic Hepatocellular Carcinoma under Hypoxia. Cancers. 14(14). 3355–3355. 8 indexed citations
13.
Kim, Dongwoo, Won-Jin Kim, Hye Won Lee, et al.. (2022). Impact of Exogenous Treatment with Histidine on Hepatocellular Carcinoma Cells. Cancers. 14(5). 1205–1205. 11 indexed citations
14.
Sung, Jeong Soo, Soo‐Jeong Lee, Jaeyong Jung, et al.. (2022). One-step immunoassay for food allergens based on screened mimotopes from autodisplayed FV-antibody library. Biosensors and Bioelectronics. 202. 113976–113976. 23 indexed citations
15.
Lee, Misu, et al.. (2018). Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma. Yonsei Medical Journal. 59(10). 1143–1143. 35 indexed citations
16.
Yoo, Gu, Ji-Hong Bong, Misu Lee, et al.. (2017). Autodisplay of the La/SSB protein on LPS-free E. coli for the diagnosis of Sjögren’s syndrome. Enzyme and Microbial Technology. 100. 1–10. 9 indexed citations
17.
Lee, Misu, Tobias Wiedemann, Martin Irmler, et al.. (2016). Targeting PI3K/mTOR signaling exerts potent antitumor activity in pheochromocytoma in vivo. Endocrine Related Cancer. 24(1). 1–15. 13 indexed citations
18.
Lee, Misu, Tobias Wiedemann, Claudia Groß, et al.. (2015). Targeting PI3K/mTOR Signaling Displays Potent Antitumor Efficacy against Nonfunctioning Pituitary Adenomas. Clinical Cancer Research. 21(14). 3204–3215. 48 indexed citations
19.
Lee, Misu, Marily Theodoropoulou, Jochen Graw, et al.. (2011). Levels of p27 Sensitize to Dual PI3K/mTOR Inhibition. Molecular Cancer Therapeutics. 10(8). 1450–1459. 36 indexed citations
20.
Molatore, Sara, Eva Kiermaier, Christian Billy Jung, et al.. (2010). Characterization of a naturally-occurring p27 mutation predisposing to multiple endocrine tumors. Molecular Cancer. 9(1). 116–116. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanjay Thamake Breakdown of academic impact, for papers by Ronald J. Bernardi Breakdown of academic impact, for papers by Letícia Labriola Breakdown of academic impact, for papers by Heming Li Breakdown of academic impact, for papers by Patrick Delavault Breakdown of academic impact, for papers by Mozhdeh Sojoodi Breakdown of academic impact, for papers by Pietro Di Fazio Breakdown of academic impact, for papers by Mikhail M. Dikov Breakdown of academic impact, for papers by Hisanori Kosuge Breakdown of academic impact, for papers by Weiye Deng
Rankless by CCL
2026